ALX Oncology Holdings, Inc. (ALXO)
1.26
-0.07
(-5.26%)
USD |
NASDAQ |
Dec 29, 16:00
1.28
+0.02
(+1.59%)
After-Hours: 20:00
ALX Oncology Holdings Market Cap: 68.31M for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 52.69B |
| Prelude Therapeutics, Inc. | 184.82M |
| Erasca, Inc. | 981.64M |
| Immuneering Corp. | 430.04M |
| CEL-SCI Corp. | 15.75M |
Market Cap Related Metrics
| Price to Book Value | 1.525 |
| Price | 1.26 |
| Earnings Yield | -160.9% |